2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- structure
|
Common Name | 2,6-Naphthyridin-1(2H)-one, 3,4-dihydro- | ||
---|---|---|---|---|
CAS Number | 58553-56-3 | Molecular Weight | 148.16200 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C8H8N2O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | 3,4-dihydro-2H-2,6-naphthyridin-1-one |
---|---|
Synonym | More Synonyms |
Molecular Formula | C8H8N2O |
---|---|
Molecular Weight | 148.16200 |
Exact Mass | 148.06400 |
PSA | 41.99000 |
LogP | 0.69630 |
~27% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 1018 ; |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 2,6-Naphthyridi... CAS#:58553-56-3 |
Literature: Meiji Seika Kaisha, Ltd. Patent: EP1180514 A1, 2002 ; Location in patent: Example 104 ; |
3,4-dihydro-2H-[2,6]naphthyridin-1-one |
Tetrahydro-2,6-naphthyridin-1-on |
3,4-dihydro-2,6-naphthyridin-1(2H)-one |
1,2,3,4-Tetrahydro-2,6-naphthyridin-1-on |
1,2,3,4-TETRAHYDRO-2,6-NAPHTHYRIDIN-1-ONE |